Obstetrics and Gynecology, Lehigh Valley Health Network, Allentown, Pennsylvania, USA.
USF Health Morsani College of Medicine, Tampa, Florida, USA.
BMJ Case Rep. 2021 Sep 17;14(9):e244716. doi: 10.1136/bcr-2021-244716.
Haemophagocytic lymphohistiocytosis (HLH) is a rare, often fatal disease, and presents a diagnostic challenge in the pregnant patient. This challenge is particularly relevant during the current COVID-19 pandemic. We present a case of HLH in a pregnant woman presenting with fever predating the COVID-19 pandemic. A 33-year-old, gravida 2, para 1 at 27 weeks' gestation presented with fever, transaminitis, thrombocytopenia and elevated ferritin. After treatment according to the HLH-94 protocol, caesarean delivery and weeks of intensive care, the patient recovered fully. With prompt diagnosis and a multispecialty team at our tertiary care facility, she and her baby overcame a dire prognosis. HLH should be considered in pregnant patients presenting with a febrile illness. Particularly in cases of severe COVID-19, secondary HLH must be considered as an associated diagnosis.
噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见的、常致命的疾病,在孕妇中诊断具有挑战性。在当前的 COVID-19 大流行期间,这一挑战尤其相关。我们报告了一例 COVID-19 大流行前发热的孕妇 HLH 病例。一名 33 岁、妊娠 2 次、产 1 次的 27 周孕妇因发热、肝转氨酶升高、血小板减少和铁蛋白升高就诊。根据 HLH-94 方案治疗、剖宫产和数周重症监护后,患者完全康复。在我们的三级医疗中心,通过及时诊断和多学科团队合作,她和她的宝宝克服了严峻的预后。HLH 应被视为发热孕妇的一种疾病。特别是在严重 COVID-19 的情况下,必须考虑继发性 HLH 作为相关诊断。